pentobarbital will decrease the extent or outcome of ripretinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism.Monitor Carefully (1)pentobarbital will decrease the level or impact of exemestane by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of. For people getting exemestane with a powerful CYP3A4 induce